Abstract
Background
Intravitreal injections are the fastest growing cause of endophthalmitis and can result in severe vision loss. The prevention, diagnosis and management of such infections remain unclear and at times controversial.
Methods
We searched Pubmed for keywords "prophylaxis," "endophthalmitis," "intravitreal injection." We focused on studies published in the last 2 years as well as other recent studies with particular attention to data on the incidence, microbiology, prevention, and treatment of injection-related endophthalmitis.
Results
Over 20 relevant studies were found. With povidone–iodine preparation, the per–injection endophthalmitis rate is low at about 0.03%. Antibiotics do not appear to be beneficial for prevention of post–injection endophthalmitis. The best timing of vitrectomy is unclear.
Conclusions
Antibiotic prophylaxis is probably not needed when giving intravitreal injections. More data is needed to help determine the proper treatment for post-injection endophthalmitis.
References
Lanzetta P, Mitchell P, Wolf S, Veritti D (2013) Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review. Br J Ophthalmol 97:1497–1507
Brechner RJ, Rosenfeld PJ, Babish JD, Caplan S (2011) Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file. Am J Ophthalmol 151:887–895
Durand ML (2013) Endophthalmitis. Clin Microbiol Infect 19:227–234
Englander M, Chen TC, Paschalis EI, Miller JW, Kim IK (2013) Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Br J Ophthalmol 97:460–465
Lyall DA, Tey A, Foot B et al (2012) Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) 26:1517–1526
Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr et al (2011) Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina 31:662–668
McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 31:654–661
Simunovic MP, Rush RB, Hunyor AP, Chang AA (2012) Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 96:862–866
Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ (2008) Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model. J Ocul Pharmacol Ther 24:1–7
Shimada H, Hattori T, Mori R, Nakashizuka H, Fujita K, Yuzawa M (2013) Minimizing the endophthalmitis rate following intravitreal injections using 0.25 % povidone–iodine irrigation and surgical mask. Graefes Arch Clin Exp Ophthalmol 251:1885–1890
Moss JM, Sanislo SR, Ta CN (2009) A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 116:1498–1501
Bhavsar AR, Googe JM Jr, Stockdale CR et al (2009) Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser–ranibizumab–triamcinolone clinical trials. Arch Ophthalmol 127:1581–1583
Bhavsar AR, Stockdale CR, Ferris FL 3rd, Brucker AJ, Bressler NM, Glassman AR (2012) Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. Arch Ophthalmol 130:809–810
Bhatt SS, Stepien KE, Joshi K (2011) Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina 31:2032–2036
Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC (2012) Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 119:1609–1614
Storey P, Dollin M, Pitcher J et al (2014) The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Ophthalmology 121:283–289
Yin VT, Weisbrod DJ, Eng KT et al (2013) Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA Ophthalmol 131:456–461
Kim SJ, Toma HS (2011) Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch Ophthalmol 129:1180–1188
Dave SB, Toma HS, Kim SJ (2013) Changes in ocular flora in eyes exposed to ophthalmic antibiotics. Ophthalmology 120:937–941
Friedman DA, Mason JO 3rd, Emond T, McGwin G Jr (2013) Povidone–iodine contact time and lid speculum use during intravitreal injection. Retina 33:975–981
Doshi RR, Leng T, Fung AE (2012) Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina 32:473–476
Goldberg RA, Flynn HW Jr, Miller D, Gonzalez S, Isom RF (2013) Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results. Ophthalmology 120:1448–1453
Sheyman AT, Cohen BZ, Friedman AH, Ackert JM (2013) An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. JAMA Ophthalmol 131:864–869
Palmer JM, Amoaku WM, Kamali F (2013) Quality of bevacizumab compounded for intravitreal administration. Eye (Lond) 27:1090–1097
Liu L, Ammar DA, Ross LA, Mandava N, Kahook MY, Carpenter JF (2011) Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling. Invest Ophthalmol Vis Sci 52:1023–1034
Chaudhary KM, Romero JM, Ezon I, Fastenberg DM, Deramo VA (2013) Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection. Retina 33:1407–1416
Irigoyen C, Ziahosseini K, Morphis G, Stappler T, Heimann H (2012) Endophthalmitis following intravitreal injections. Graefes Arch Clin Exp Ophthalmol 250:499–505
Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A (2003) Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23:686–691
Fagan XJ, Al-Qureshi S (2013) Intravitreal injections: a review of the evidence for best practice. Clin Experiment Ophthalmol 41(5):500–507
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, C.Q., Ta, C.N. Prevention and treatment of injection-related endophthalmitis. Graefes Arch Clin Exp Ophthalmol 252, 1027–1031 (2014). https://doi.org/10.1007/s00417-014-2644-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-014-2644-0